Alto Neuroscience, Inc.'s total assets for Q2 2025 were $157.88M, a decrease of -8.17% from the previous quarter. ANRO total liabilities were $34.47M for the fiscal quarter, a 5.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.